首页 > 最新文献

Therapeutic Advances in Urology最新文献

英文 中文
The outcomes of penile prosthesis in neurologic patients: a multicentric retrospective series. 神经系统患者阴茎假体的结果:一个多中心回顾性系列。
IF 2 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/17562872231194921
Marco Falcone, Paolo Capogrosso, Lorenzo Cirigliano, Paolo Geretto, Mirko Preto, Massimiliano Timpano, Carlo Ceruti, Federica Peretti, Ilaria Ferro, Natalia Plamadeala, Federico Dehò, Carlo Bettocchi, Celeste Manfredi, Lorenzo Spirito, Alessandro Palmieri, Alberto Manassero, Gideon Blecher, Paolo Gontero
Introduction: Neurological disease is a known entity for causing erectile dysfunction (ED). Pharmacological therapies are not always effective these patients – penile prosthesis implant (PPI) is an established surgical treatment option. For a variety of reasons, neurological patients may experience differing outcomes of PPI compared to those whose ED arises from other causes. We investigated outcomes of PPI in neurological patients using the Italian multi-institutional national registry of penile prostheses [Italian Nationwide Systematic Inventarization of Surgical Treatment for ED (INSIST-ED)]. Methods: Patients undergoing PPI were investigated via the INSIST-ED registry, from 2014 to 2021. Data were prospectively recorded by 45 surgeons on a dedicated website (www.registro.andrologiaitaliana.it) and reviewed by a data manager. We subselected patients with neurological disease undergoing PPI for ED, and these patients were reviewed at 3, 6, and 12 months, and annually thereafter. Postoperative complications and functional outcomes were evaluated through validated questionnaires [International Index of Erectile Function-5 (IIEF-5), Sexual Encounter Profile 2–3, and Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS)]. A nonvalidated questionnaire was administered to assess patient satisfaction. Results: A total of 33 patients were included with a median age of 49 [interquartile range (IQR) 41–55]. Median follow-up was 83 months (IQR 67–99.5). A penoscrotal approach for PPI was performed in most cases (90.9%), while infrapubic was used in three cases (9.1%). Inflatable and malleable devices were implanted in 30 (90.9%) and 3 cases (9.1%), respectively. Intraoperative complications occurred in one case (3%). Early postoperative complications (<90 days) were observed in three cases (9.1%): two wound dehiscence (Clavien-Dindo G1 and G3a respectively) and one device infection requiring prosthesis explant (Clavien-Dindo G3a). Mechanical failures of inflatable devices were not observed during the follow-up period. Median IIEF-5 before surgery was 8 (IQR 7–9). At the latest follow-up, IIEF-5 was 22 (IQR 19–23.5), and median EDITS was 79 (IQR 64–88). A total of 28 patients (84.8%) self-reported to be fully satisfied with the PPI. Conclusion: Although PPI in the neurological population has been historically considered to be at increased risk, in our study, PPI complications and infections rates in this cohort did not differ from general population.
简介:神经系统疾病是引起勃起功能障碍(ED)的已知实体。药物治疗并不总是有效的这些患者-阴茎假体植入(PPI)是一种既定的手术治疗选择。由于各种原因,与其他原因引起ED的患者相比,神经系统患者可能经历不同的PPI结果。我们使用意大利多机构阴茎假体国家注册表[意大利全国ED手术治疗系统发明化(坚持-ED)]调查了神经系统患者PPI的结果。方法:从2014年到2021年,通过persist - ed登记对接受PPI的患者进行调查。数据由45名外科医生在一个专门的网站(www.registro.andrologiaitaliana.it)上进行前瞻性记录,并由数据管理员进行审查。我们亚选择了接受PPI治疗ED的神经系统疾病患者,并在3、6和12个月时对这些患者进行了回顾,此后每年一次。通过有效问卷[国际勃起功能指数-5 (IIEF-5),性接触概况2-3和勃起功能障碍治疗满意度量表(EDITS)]评估术后并发症和功能结局。采用一份未经验证的问卷来评估患者满意度。结果:共纳入33例患者,中位年龄49岁[四分位间距(IQR) 41-55]。中位随访83个月(IQR 67-99.5)。大多数病例(90.9%)采用耻骨下入路进行PPI, 3例(9.1%)采用耻骨下入路。可充气装置30例(90.9%),可延展装置3例(9.1%)。术中出现并发症1例(3%)。结论:尽管既往认为神经系统人群的PPI风险增加,但在我们的研究中,该队列的PPI并发症和感染率与一般人群没有差异。
{"title":"The outcomes of penile prosthesis in neurologic patients: a multicentric retrospective series.","authors":"Marco Falcone,&nbsp;Paolo Capogrosso,&nbsp;Lorenzo Cirigliano,&nbsp;Paolo Geretto,&nbsp;Mirko Preto,&nbsp;Massimiliano Timpano,&nbsp;Carlo Ceruti,&nbsp;Federica Peretti,&nbsp;Ilaria Ferro,&nbsp;Natalia Plamadeala,&nbsp;Federico Dehò,&nbsp;Carlo Bettocchi,&nbsp;Celeste Manfredi,&nbsp;Lorenzo Spirito,&nbsp;Alessandro Palmieri,&nbsp;Alberto Manassero,&nbsp;Gideon Blecher,&nbsp;Paolo Gontero","doi":"10.1177/17562872231194921","DOIUrl":"https://doi.org/10.1177/17562872231194921","url":null,"abstract":"Introduction: Neurological disease is a known entity for causing erectile dysfunction (ED). Pharmacological therapies are not always effective these patients – penile prosthesis implant (PPI) is an established surgical treatment option. For a variety of reasons, neurological patients may experience differing outcomes of PPI compared to those whose ED arises from other causes. We investigated outcomes of PPI in neurological patients using the Italian multi-institutional national registry of penile prostheses [Italian Nationwide Systematic Inventarization of Surgical Treatment for ED (INSIST-ED)]. Methods: Patients undergoing PPI were investigated via the INSIST-ED registry, from 2014 to 2021. Data were prospectively recorded by 45 surgeons on a dedicated website (www.registro.andrologiaitaliana.it) and reviewed by a data manager. We subselected patients with neurological disease undergoing PPI for ED, and these patients were reviewed at 3, 6, and 12 months, and annually thereafter. Postoperative complications and functional outcomes were evaluated through validated questionnaires [International Index of Erectile Function-5 (IIEF-5), Sexual Encounter Profile 2–3, and Erectile Dysfunction Inventory of Treatment Satisfaction (EDITS)]. A nonvalidated questionnaire was administered to assess patient satisfaction. Results: A total of 33 patients were included with a median age of 49 [interquartile range (IQR) 41–55]. Median follow-up was 83 months (IQR 67–99.5). A penoscrotal approach for PPI was performed in most cases (90.9%), while infrapubic was used in three cases (9.1%). Inflatable and malleable devices were implanted in 30 (90.9%) and 3 cases (9.1%), respectively. Intraoperative complications occurred in one case (3%). Early postoperative complications (<90 days) were observed in three cases (9.1%): two wound dehiscence (Clavien-Dindo G1 and G3a respectively) and one device infection requiring prosthesis explant (Clavien-Dindo G3a). Mechanical failures of inflatable devices were not observed during the follow-up period. Median IIEF-5 before surgery was 8 (IQR 7–9). At the latest follow-up, IIEF-5 was 22 (IQR 19–23.5), and median EDITS was 79 (IQR 64–88). A total of 28 patients (84.8%) self-reported to be fully satisfied with the PPI. Conclusion: Although PPI in the neurological population has been historically considered to be at increased risk, in our study, PPI complications and infections rates in this cohort did not differ from general population.","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f0/43/10.1177_17562872231194921.PMC10472821.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10153739","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Robotic-assisted simple prostatectomy: long-term, trifecta- and pentafecta-based analysis of functional outcomes 机器人辅助的简单前列腺切除术:基于三效和五效的长期功能结果分析
IF 2 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/17562872221147104
A. Bove, A. Brassetti, Mario Ochoa, U. Anceschi, M. Ferriero, G. Tuderti, L. Misuraca, R. Mastroianni, Silvia Cartolano, S. D'annunzio, Giulia Torreggiani, G. Simone
Robotic-assisted simple prostatectomy (RASP) proved to be a sound and effective procedure for bladder outlet obstructive symptoms relief. Routinely, the transvesical (Freyer) or transcapsular (Millin) techniques are performed. A novel approach of near-infrared fluorescence imaging (NIFI)-guided urethra-sparing robot-assisted prostatectomy (Madigan) was recently introduced. The aim of our study was to evaluate the long-term functional outcomes between the Millin, Freyer, and Madigan RASP. This is a single-center, retrospective evaluation of a prospectively maintained Institutional Review Board–approved database. Data from patients who have undergone RASP in our center were prospectively collected. Demographics, prostate size, and preoperative flowmetry parameters were assessed. Questionnaires such as International Index of Erectile Function (IIEF), and International Consultation on Incontinence Questionnaire (ICIQ), International prostatic symptoms score (IPSS) with its quality of life (QoL) score, Male Sexual Health Questionnaire (MSHQ), Overactive bladder questionnaire (OABQ) were administered to every patient preoperatively and during follow-up. We tested composite outcomes (trifecta) defined as a combination of postoperative Q-max >15 ml/s, IPSS score < 8, and absence of complications. We also tested a pentafecta which keeps in account the persistence of antegrade ejaculation (MSHQ > 0) and the erectile function maintenance (∆IEEF < 6). Median follow-up was 36 months. Millin, Madigan, and Freyer procedures were performed in 37 (51%), 18 (25%), and 17 (24%) cases, respectively. Trifecta was achieved in 43 (60%) patients. Preoperative ICIQ, postoperative IPSS, postoperative OABQ, and QoL were significantly different between groups (all p < 0.02). Pentafecta was achieved by 14 (20%) patients. The pentafecta group showed a statistically significant advantage in terms of postoperative IPSS and MSHQ ( p < 0.01). RASP provides an effective and durable relief of obstructive symptoms at long-term follow-up, regardless of the technique, achieving the trifecta in the majority of the patients. The Madigan technique is significantly related to the pentafecta achievement.
机器人辅助简易前列腺切除术(RASP)被证明是缓解膀胱出口梗阻症状的一种可靠有效的方法。通常,进行经膀胱(Freyer)或经囊(Millin)技术。最近介绍了一种新的近红外荧光成像(NIFI)引导的尿道保留机器人辅助前列腺切除术(Madigan)。我们研究的目的是评估Millin、Freyer和Madigan RASP之间的长期功能结果。这是对前瞻性维护的机构审查委员会批准的数据库进行的单中心回顾性评估。前瞻性地收集了在我们中心接受RASP的患者的数据。评估了人口学、前列腺大小和术前流量测量参数。术前和随访期间,对每位患者进行国际勃起功能指数(IIEF)、国际失禁咨询问卷(ICIQ)、国际前列腺症状评分(IPSS)及其生活质量(QoL)、男性性健康问卷(MSHQ)、膀胱过度活动问卷(OABQ)等问卷调查。我们测试了复合结果(三联),定义为术后Q-max>15 ml/s、IPSS评分的组合  0)和勃起功能维持(∆IEEF < 6) 。中位随访时间为36个月。Millin、Madigan和Freyer手术分别在37例(51%)、18例(25%)和17例(24%)中进行。在43名(60%)患者中实现了Trifecta。术前ICIQ、术后IPSS、术后OABQ和生活质量在各组之间有显著差异(均p < 0.02)。14名(20%)患者获得了Pentaffecta。Pentaffecta组在术后IPSS和MSHQ方面显示出统计学上显著的优势(p < 0.01)。RASP在长期随访中对梗阻症状提供了有效和持久的缓解,无论采用何种技术,在大多数患者中都实现了三重切除。Madigan技术与pentafecta的成就有很大关系。
{"title":"Robotic-assisted simple prostatectomy: long-term, trifecta- and pentafecta-based analysis of functional outcomes","authors":"A. Bove, A. Brassetti, Mario Ochoa, U. Anceschi, M. Ferriero, G. Tuderti, L. Misuraca, R. Mastroianni, Silvia Cartolano, S. D'annunzio, Giulia Torreggiani, G. Simone","doi":"10.1177/17562872221147104","DOIUrl":"https://doi.org/10.1177/17562872221147104","url":null,"abstract":"Robotic-assisted simple prostatectomy (RASP) proved to be a sound and effective procedure for bladder outlet obstructive symptoms relief. Routinely, the transvesical (Freyer) or transcapsular (Millin) techniques are performed. A novel approach of near-infrared fluorescence imaging (NIFI)-guided urethra-sparing robot-assisted prostatectomy (Madigan) was recently introduced. The aim of our study was to evaluate the long-term functional outcomes between the Millin, Freyer, and Madigan RASP. This is a single-center, retrospective evaluation of a prospectively maintained Institutional Review Board–approved database. Data from patients who have undergone RASP in our center were prospectively collected. Demographics, prostate size, and preoperative flowmetry parameters were assessed. Questionnaires such as International Index of Erectile Function (IIEF), and International Consultation on Incontinence Questionnaire (ICIQ), International prostatic symptoms score (IPSS) with its quality of life (QoL) score, Male Sexual Health Questionnaire (MSHQ), Overactive bladder questionnaire (OABQ) were administered to every patient preoperatively and during follow-up. We tested composite outcomes (trifecta) defined as a combination of postoperative Q-max >15 ml/s, IPSS score < 8, and absence of complications. We also tested a pentafecta which keeps in account the persistence of antegrade ejaculation (MSHQ > 0) and the erectile function maintenance (∆IEEF < 6). Median follow-up was 36 months. Millin, Madigan, and Freyer procedures were performed in 37 (51%), 18 (25%), and 17 (24%) cases, respectively. Trifecta was achieved in 43 (60%) patients. Preoperative ICIQ, postoperative IPSS, postoperative OABQ, and QoL were significantly different between groups (all p < 0.02). Pentafecta was achieved by 14 (20%) patients. The pentafecta group showed a statistically significant advantage in terms of postoperative IPSS and MSHQ ( p < 0.01). RASP provides an effective and durable relief of obstructive symptoms at long-term follow-up, regardless of the technique, achieving the trifecta in the majority of the patients. The Madigan technique is significantly related to the pentafecta achievement.","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"48599730","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Sedation as an alternative anesthetic technique for frail patients in transurethral resection of the prostate. 镇静作为虚弱病人经尿道前列腺切除术的替代麻醉技术。
IF 2 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/17562872221150217
Christian Habib Ayoub, Viviane Chalhoub, Adnan El-Achkar, Nassib Abou Heidar, Hani Tamim, Marie Maroun-Aouad, Albert El Hajj

Background: Transurethral resection of the prostate (TURP) under Monitored Anesthesia Care MAC/Sedation (macTURP), as compared with TURP under general (genTURP) or spinal (spTURP) anesthesia, is a safer and infrequently used technique reserved for high-risk patients.

Objectives: The aim of this study is to compare 30-day postoperative outcomes of TURP using the three types of anesthesia techniques.

Design and methods: The American College of Surgeons National Surgical Quality Improvement Program database was queried for patients who underwent TURP between 2008 and 2019. Demographics, lab values, medical history, and 30-day outcomes were compared. Univariate and multivariate regression models for postoperative complications were constructed. A propensity score-matched analysis was then performed for genTURP and macTURP and for spTURP and macTURP as a sensitivity analysis.

Results: A total of 53,182 patients underwent TURP. Older patients (>80) with diabetes requiring insulin (7.9%), leukocytosis (7.4%), history of chronic obstructive pulmonary disease (COPD) (7.8%), dyspnea (7.2%), and of ASA > 2 (58.8%) were more likely to undergo macTURP as compared with genTURP (p < 0.013). SpTURP showed lower rates of urinary tract infection (UTI) [odds ratio (OR) = 0.869] as compared with genTURP (p = 0.049), whereas macTURP showed higher rates of major adverse cardiovascular events (OR = 2.179) as compared with genTURP (p = 0.005). All other postoperative complications showed similar rates between the three procedures. The propensity-matched cohorts demonstrated that no differences in postoperative complication rates were noted between macTURP and genTURP and between macTURP and spTURP.

Conclusion: MacTURP was found to be feasible with a good safety profile as compared with genTURP and spTURP. MacTURP could be used in elderly, frail, and co-morbid patients with a similar safety profile as compared with more invasive anesthetic techniques.

背景:与全身麻醉(genTURP)或脊柱麻醉(spTURP)下的经尿道前列腺切除术(TURP)相比,MAC/镇静麻醉(macTURP)下的经尿道前列腺切除术(TURP)是一种更安全且不常用于高危患者的技术。目的:本研究的目的是比较三种麻醉技术在TURP术后30天的预后。设计和方法:查询2008年至2019年期间接受TURP治疗的患者的美国外科医师学会国家手术质量改进计划数据库。比较人口统计学、实验室值、病史和30天结果。建立了术后并发症的单因素和多因素回归模型。然后对genTURP和macTURP进行倾向评分匹配分析,并对spTURP和macTURP进行敏感性分析。结果:53,182例患者接受了TURP。与genTURP (p = 0.049)相比,有糖尿病需要胰岛素(7.9%)、白细胞增多(7.4%)、慢性阻塞性肺疾病(COPD)病史(7.8%)、呼吸困难(7.2%)和ASA > 2(58.8%)的老年患者(>80)更有可能接受macTURP治疗(p = 0.049),而macTURP的主要不良心血管事件发生率(OR = 2.179)高于genTURP (p = 0.005)。所有其他术后并发症的发生率在三种手术之间相似。倾向匹配的队列显示,macTURP和genTURP以及macTURP和spTURP之间的术后并发症发生率没有差异。结论:与genTURP和spTURP相比,MacTURP是可行的,具有良好的安全性。MacTURP可用于老年、体弱和合并症患者,与更具侵入性的麻醉技术相比,其安全性相似。
{"title":"Sedation as an alternative anesthetic technique for frail patients in transurethral resection of the prostate.","authors":"Christian Habib Ayoub,&nbsp;Viviane Chalhoub,&nbsp;Adnan El-Achkar,&nbsp;Nassib Abou Heidar,&nbsp;Hani Tamim,&nbsp;Marie Maroun-Aouad,&nbsp;Albert El Hajj","doi":"10.1177/17562872221150217","DOIUrl":"https://doi.org/10.1177/17562872221150217","url":null,"abstract":"<p><strong>Background: </strong>Transurethral resection of the prostate (TURP) under Monitored Anesthesia Care MAC/Sedation (macTURP), as compared with TURP under general (genTURP) or spinal (spTURP) anesthesia, is a safer and infrequently used technique reserved for high-risk patients.</p><p><strong>Objectives: </strong>The aim of this study is to compare 30-day postoperative outcomes of TURP using the three types of anesthesia techniques.</p><p><strong>Design and methods: </strong>The American College of Surgeons National Surgical Quality Improvement Program database was queried for patients who underwent TURP between 2008 and 2019. Demographics, lab values, medical history, and 30-day outcomes were compared. Univariate and multivariate regression models for postoperative complications were constructed. A propensity score-matched analysis was then performed for genTURP and macTURP and for spTURP and macTURP as a sensitivity analysis.</p><p><strong>Results: </strong>A total of 53,182 patients underwent TURP. Older patients (>80) with diabetes requiring insulin (7.9%), leukocytosis (7.4%), history of chronic obstructive pulmonary disease (COPD) (7.8%), dyspnea (7.2%), and of ASA > 2 (58.8%) were more likely to undergo macTURP as compared with genTURP (<i>p</i> < 0.013). SpTURP showed lower rates of urinary tract infection (UTI) [odds ratio (OR) = 0.869] as compared with genTURP (<i>p</i> = 0.049), whereas macTURP showed higher rates of major adverse cardiovascular events (OR = 2.179) as compared with genTURP (<i>p</i> = 0.005). All other postoperative complications showed similar rates between the three procedures. The propensity-matched cohorts demonstrated that no differences in postoperative complication rates were noted between macTURP and genTURP and between macTURP and spTURP.</p><p><strong>Conclusion: </strong>MacTURP was found to be feasible with a good safety profile as compared with genTURP and spTURP. MacTURP could be used in elderly, frail, and co-morbid patients with a similar safety profile as compared with more invasive anesthetic techniques.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/30/07/10.1177_17562872221150217.PMC9869224.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9178525","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Management of the urological tract in children with anorectal malformations - a contemporary review. 肛肠畸形儿童泌尿道的处理——当代综述。
IF 2 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/17562872231161468
Kelly T Harris, Duncan T Wilcox

Anorectal malformations (ARMs) consist of a broad spectrum of congenital anomalies that are associated with an equally wide variety of urological abnormalities, often with increasing incidence as the severity of the ARM increases. The importance of urologic involvement in the care of ARM patients has been noted for decades and is critical from birth to adulthood. Urology must be involved in the initial evaluation and operative care of the child as well as in monitoring and managing issues such as neurogenic bladder, renal disease, and eventually sexual function and fertility. Care of the ARM patient must be done through a multidisciplinary lens, with the urologist as a key player. This review will serve as an update on the management of the urologic tract in children with ARM.

肛门直肠畸形(ARMs)由广泛的先天性异常组成,这些先天性异常与同样广泛的泌尿系统异常相关,通常随着ARM严重程度的增加而增加。数十年来,人们一直注意到泌尿系统介入对ARM患者护理的重要性,并且从出生到成年都至关重要。泌尿外科必须参与儿童的初步评估和手术护理,以及监测和管理问题,如神经源性膀胱,肾脏疾病,最终性功能和生育能力。ARM患者的护理必须通过多学科的视角来完成,泌尿科医生是关键的参与者。本综述将作为对ARM患儿泌尿道管理的最新研究。
{"title":"Management of the urological tract in children with anorectal malformations - a contemporary review.","authors":"Kelly T Harris,&nbsp;Duncan T Wilcox","doi":"10.1177/17562872231161468","DOIUrl":"https://doi.org/10.1177/17562872231161468","url":null,"abstract":"<p><p>Anorectal malformations (ARMs) consist of a broad spectrum of congenital anomalies that are associated with an equally wide variety of urological abnormalities, often with increasing incidence as the severity of the ARM increases. The importance of urologic involvement in the care of ARM patients has been noted for decades and is critical from birth to adulthood. Urology must be involved in the initial evaluation and operative care of the child as well as in monitoring and managing issues such as neurogenic bladder, renal disease, and eventually sexual function and fertility. Care of the ARM patient must be done through a multidisciplinary lens, with the urologist as a key player. This review will serve as an update on the management of the urologic tract in children with ARM.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/ac/34/10.1177_17562872231161468.PMC10034273.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9245940","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Patterns of use of medications used to treat urinary incontinence and potentially inappropriate prescriptions. 用于治疗尿失禁的药物的使用模式和可能不适当的处方。
IF 2 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/17562872231179104
Luis Fernando Valladales-Restrepo, Hugo Alejandro Bedoya-Arias, Brayan Stiven Aristizábal-Carmona, Jorge Enrique Machado-Alba

Background: The pharmacological treatment of urinary incontinence (UI) may involve bladder antimuscarinics, which can generate risks in the elderly.

Objective: The aim was to determine the treatment patterns of a group of patients with UI and possible potentially inappropriate prescriptions.

Design and methods: This was a cross-sectional study that identified prescription patterns of medications for outpatient use in patients with UI between December 2020 and November 2021 based on a population database of members of the Colombian Health System. Patients were identified based on the codes of the international classification of diseases, version-10. Sociodemographic and pharmacological variables were considered.

Results: A total of 9855 patients with UI were identified, with a median age of 72 years, and 74.6% were women. Unspecified UI was the most frequent form (83.2%), followed by specified UI (7.9%), stress UI (6.7%), and UI associated with an overactive bladder (2.2%). A total of 37.2% received pharmacological treatment, mainly with bladder antimuscarinics (22.6%), mirabegron (15.6%), and topical estrogens (7.9%). Pharmacological management predominated in UI associated with overactive bladder, in women and in patients between 50 and 79 years of age. Of the patients who received bladder antimuscarinics, 54.5% were 65 years old or older, and 21.5% also had benign prostatic hyperplasia, sicca syndrome, glaucoma, constipation, or dementia. A total of 2.0% of women had been prescribed systemic estrogens and 1.7% had been prescribed peripheral α-adrenergic antagonists.

Conclusion: Differences in the prescriptions were found according to the type of UI, sex, and age group. Potentially inappropriate or risky prescriptions were common.

背景:尿失禁(UI)的药物治疗可能涉及膀胱抗尿毒药物,这在老年人中可能产生风险。目的:目的是确定一组尿失禁患者的治疗模式和可能不适当的处方。设计和方法:这是一项横断面研究,根据哥伦比亚卫生系统成员的人口数据库,确定了2020年12月至2021年11月期间UI患者门诊用药的处方模式。病人是根据国际疾病分类第10版的代码确定的。考虑了社会人口学和药理学变量。结果:共确诊尿失禁患者9855例,中位年龄72岁,女性占74.6%。未明确的尿失禁是最常见的形式(83.2%),其次是明确的尿失禁(7.9%)、应激性尿失禁(6.7%)和伴有膀胱过度活动的尿失禁(2.2%)。37.2%的患者接受了药物治疗,主要是膀胱抗蛇毒素(22.6%)、米拉贝隆(15.6%)和外用雌激素(7.9%)。在50 - 79岁的女性和患者中,与膀胱过度活动相关的尿失禁以药物治疗为主。在接受膀胱抗毒蕈素治疗的患者中,54.5%的患者年龄在65岁及以上,21.5%的患者同时患有良性前列腺增生、干燥综合征、青光眼、便秘或痴呆。总共有2.0%的女性服用了全身性雌激素,1.7%的女性服用了外周α-肾上腺素能拮抗剂。结论:根据尿失禁类型、性别、年龄组不同,处方存在差异。可能不合适或有风险的处方很常见。
{"title":"Patterns of use of medications used to treat urinary incontinence and potentially inappropriate prescriptions.","authors":"Luis Fernando Valladales-Restrepo,&nbsp;Hugo Alejandro Bedoya-Arias,&nbsp;Brayan Stiven Aristizábal-Carmona,&nbsp;Jorge Enrique Machado-Alba","doi":"10.1177/17562872231179104","DOIUrl":"https://doi.org/10.1177/17562872231179104","url":null,"abstract":"<p><strong>Background: </strong>The pharmacological treatment of urinary incontinence (UI) may involve bladder antimuscarinics, which can generate risks in the elderly.</p><p><strong>Objective: </strong>The aim was to determine the treatment patterns of a group of patients with UI and possible potentially inappropriate prescriptions.</p><p><strong>Design and methods: </strong>This was a cross-sectional study that identified prescription patterns of medications for outpatient use in patients with UI between December 2020 and November 2021 based on a population database of members of the Colombian Health System. Patients were identified based on the codes of the international classification of diseases, version-10. Sociodemographic and pharmacological variables were considered.</p><p><strong>Results: </strong>A total of 9855 patients with UI were identified, with a median age of 72 years, and 74.6% were women. Unspecified UI was the most frequent form (83.2%), followed by specified UI (7.9%), stress UI (6.7%), and UI associated with an overactive bladder (2.2%). A total of 37.2% received pharmacological treatment, mainly with bladder antimuscarinics (22.6%), mirabegron (15.6%), and topical estrogens (7.9%). Pharmacological management predominated in UI associated with overactive bladder, in women and in patients between 50 and 79 years of age. Of the patients who received bladder antimuscarinics, 54.5% were 65 years old or older, and 21.5% also had benign prostatic hyperplasia, sicca syndrome, glaucoma, constipation, or dementia. A total of 2.0% of women had been prescribed systemic estrogens and 1.7% had been prescribed peripheral α-adrenergic antagonists.</p><p><strong>Conclusion: </strong>Differences in the prescriptions were found according to the type of UI, sex, and age group. Potentially inappropriate or risky prescriptions were common.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/69/fa/10.1177_17562872231179104.PMC10278437.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9709973","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Under pressure: irrigation practice patterns during flexible ureteroscopy. 压力下:输尿管软镜下的灌洗方式。
IF 2 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/17562872231179009
Bassel Salka, Jamsheed Bahaee, Jeff Plott, Khurshid R Ghani

Introduction: Irrigation parameters during flexible ureteroscopy (fURS) may impact patient outcomes, yet there are limited data on current practice patterns of irrigation methods and parameter selection. We assessed the common irrigation methods, pressure settings, and situations that present the most problems with irrigation among worldwide endourologists.

Methods: A questionnaire on fURS practice patterns was sent to Endourology Society members in January 2021. Responses were collected through QualtricsXM over a 1-month period. The study was reported according to the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). Surgeons were from North America (the United States and Canada), Latin America, Europe, Asia, Africa, and Oceania.

Results: Questionnaires were answered by 208 surgeons (response rate 14%). North American surgeons accounted for 36% of respondents; 29% Europe, 18% Asia, and 14% Latin America. In North America, the most common irrigation method was the pressurized saline bag using a manual inflatable cuff (55%). Saline bag (gravity) with a bulb or syringe injection system was the most common method in Europe (45%). Automated systems were the most common method in Asia (30%). For pressures used during fURS, the majority of respondents used 75-150 mmHg. The clinical scenario which had the greatest issue with adequate irrigation was during biopsy of urothelial tumor.

Conclusion: There is variation in irrigation practices and parameter selection during fURS. North American surgeons primarily used a pressurized saline bag, in contrast to European surgeons who preferred a gravity bag with a bulb/syringe system. Overall, automated irrigation systems were not commonly used.

导读:输尿管软镜检查(fURS)中的冲洗参数可能会影响患者的预后,但目前关于冲洗方法和参数选择的实践模式的数据有限。我们评估了常见的冲洗方法,压力设置,以及在世界范围内泌尿科医生中出现的最多问题的情况。方法:于2021年1月向泌尿外科学会会员发放fURS执业模式调查问卷。通过QualtricsXM收集了1个月的回复。本研究是根据互联网电子调查报告结果清单(樱桃)进行报告的。外科医生来自北美(美国和加拿大)、拉丁美洲、欧洲、亚洲、非洲和大洋洲。结果:208名外科医生接受问卷调查,回复率为14%。北美外科医生占受访者的36%;欧洲29%,亚洲18%,拉丁美洲14%。在北美,最常见的冲洗方法是使用手动充气袖带加压生理盐水袋(55%)。盐水袋(重力)配球或注射器注射系统是欧洲最常见的方法(45%)。自动化系统是亚洲最常见的方法(30%)。对于fURS期间使用的压力,大多数受访者使用75-150 mmHg。在尿路上皮肿瘤的活检中,最大的问题是适当的冲洗。结论:灌溉方式和灌溉参数的选择存在差异。北美的外科医生主要使用加压盐水袋,而欧洲的外科医生则倾向于使用带有灯泡/注射器系统的重力袋。总的来说,自动化灌溉系统并不常用。
{"title":"Under pressure: irrigation practice patterns during flexible ureteroscopy.","authors":"Bassel Salka,&nbsp;Jamsheed Bahaee,&nbsp;Jeff Plott,&nbsp;Khurshid R Ghani","doi":"10.1177/17562872231179009","DOIUrl":"https://doi.org/10.1177/17562872231179009","url":null,"abstract":"<p><strong>Introduction: </strong>Irrigation parameters during flexible ureteroscopy (fURS) may impact patient outcomes, yet there are limited data on current practice patterns of irrigation methods and parameter selection. We assessed the common irrigation methods, pressure settings, and situations that present the most problems with irrigation among worldwide endourologists.</p><p><strong>Methods: </strong>A questionnaire on fURS practice patterns was sent to Endourology Society members in January 2021. Responses were collected through QualtricsXM over a 1-month period. The study was reported according to the Checklist for Reporting Results of Internet E-Surveys (CHERRIES). Surgeons were from North America (the United States and Canada), Latin America, Europe, Asia, Africa, and Oceania.</p><p><strong>Results: </strong>Questionnaires were answered by 208 surgeons (response rate 14%). North American surgeons accounted for 36% of respondents; 29% Europe, 18% Asia, and 14% Latin America. In North America, the most common irrigation method was the pressurized saline bag using a manual inflatable cuff (55%). Saline bag (gravity) with a bulb or syringe injection system was the most common method in Europe (45%). Automated systems were the most common method in Asia (30%). For pressures used during fURS, the majority of respondents used 75-150 mmHg. The clinical scenario which had the greatest issue with adequate irrigation was during biopsy of urothelial tumor.</p><p><strong>Conclusion: </strong>There is variation in irrigation practices and parameter selection during fURS. North American surgeons primarily used a pressurized saline bag, in contrast to European surgeons who preferred a gravity bag with a bulb/syringe system. Overall, automated irrigation systems were not commonly used.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/09/f8/10.1177_17562872231179009.PMC10285609.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9768871","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Multidisciplinary treatment (MDT) perspectives in renal cell carcinoma. 肾细胞癌的多学科治疗(MDT)前景。
IF 2 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/17562872231182216
Jeanny B Aragon-Ching, Robert Uzzo
able to achieve complete metastasectomy. 14 Metastasectomy can be achieved either with surgery or radiation. The use of stereotactic ablative radiation therapy (SABR) for oligometastatic renal cell carcinoma (ORCA) was evaluated in a meta-analysis of 28 studies, 15 which included 1602 mutually exclusive patients involving 3892 lesions with the potential benefit of effective delivery in lieu of systemic therapy, 16 potential delay of subsequent line of systemic treatment in true oligoprogressive disease or perhaps in combination with systemic therapy. The feasibility of a combination approach
{"title":"Multidisciplinary treatment (MDT) perspectives in renal cell carcinoma.","authors":"Jeanny B Aragon-Ching,&nbsp;Robert Uzzo","doi":"10.1177/17562872231182216","DOIUrl":"https://doi.org/10.1177/17562872231182216","url":null,"abstract":"able to achieve complete metastasectomy. 14 Metastasectomy can be achieved either with surgery or radiation. The use of stereotactic ablative radiation therapy (SABR) for oligometastatic renal cell carcinoma (ORCA) was evaluated in a meta-analysis of 28 studies, 15 which included 1602 mutually exclusive patients involving 3892 lesions with the potential benefit of effective delivery in lieu of systemic therapy, 16 potential delay of subsequent line of systemic treatment in true oligoprogressive disease or perhaps in combination with systemic therapy. The feasibility of a combination approach","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/8f/81/10.1177_17562872231182216.PMC10286529.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9768872","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay. 单孔机器人部分肾切除术:对围手术期预后和住院时间的影响。
IF 2 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/17562872231172834
Umberto Carbonara, Daniele Amparore, Leonardo D Borregales, Anna Caliò, Chiara Ciccarese, Pietro Diana, Selcuk Erdem, Laura Marandino, Michele Marchioni, Constantijn H J Muselaers, Carlotta Palumbo, Nicola Pavan, Angela Pecoraro, Eduard Roussel, Hannah Warren, Zhen-Jie Wu, Riccardo Campi, Riccardo Bertolo

Single-port (SP) robotic surgery is a novel technology and is at the beginning of its adoption curve in urology. The goal of this narrative review is to provide an overview of SP-robotic partial nephrectomy (PN) 4 years after the introduction of the da Vinci SP dedicated platform, focusing on perioperative outcomes, length of stay, and surgical technique. A nonsystematic review of the literature was conducted. The research included the most updated articles that referred to SP robotic PN. Since its commercial release in 2018, several institutions have reproduced robotic PN by using the SP platform, both via a transperitoneal and a retroperitoneal approach. The published SP-robotic PN series are generally based on preliminary experiences by surgeons who had previous experience with conventional multi-arms robotic platforms. The reported outcomes are encouraging. Overall, three studies reported that SP-robotic PN cases had nonsignificantly different operative time, estimated blood loss, overall complications rate, and length of stay compared to the conventional 'multi-arms' robotic PN. However, in all these series, renal masses treated by SP had overall lower complexity. Moreover, two studies underlined decreased postoperative pain as a major pro of adopting the SP system. This should reduce/avoid the need for opioids after surgery. No study compared SP-robotic versus multi-arms robotic PN in cost-effectiveness. Published experience with SP-robotic PN has reported the feasibility and safety of the approach. Preliminary results are encouraging and at least noninferior with respect to those from the multi-arms series. Prospective comparative studies with long-term oncologic and functional results are awaited to draw more definitive conclusions and better establish the more appropriate indications of SP robotics in the field of PN.

单端口(SP)机器人手术是一项新技术,在泌尿外科应用曲线的开始。这篇叙述性综述的目的是在引入达芬奇SP专用平台4年后,对SP机器人部分肾切除术(PN)进行概述,重点关注围手术期结果、住院时间和手术技术。对文献进行了非系统回顾。该研究包括了涉及SP机器人PN的最新文章。自2018年商业发布以来,已有多家机构使用SP平台通过经腹膜和后腹膜途径复制机器人PN。已发表的sp -机器人PN系列通常基于先前具有传统多臂机器人平台经验的外科医生的初步经验。报告的结果令人鼓舞。总体而言,有三项研究报告称,与传统的“多臂”机器人PN相比,sp机器人PN病例的手术时间、估计出血量、总并发症发生率和住院时间没有显著差异。然而,在所有这些系列中,SP治疗肾肿块的总体复杂性较低。此外,两项研究强调减少术后疼痛是采用SP系统的主要优点。这将减少/避免手术后对阿片类药物的需求。没有研究比较sp机器人和多臂机器人PN的成本效益。已发表的sp -机器人PN的经验报告了该方法的可行性和安全性。初步结果是令人鼓舞的,至少不逊色于那些来自多臂系列。等待长期肿瘤学和功能结果的前瞻性比较研究,以得出更明确的结论,并更好地建立SP机器人在PN领域更合适的适应症。
{"title":"Single-port robotic partial nephrectomy: impact on perioperative outcomes and hospital stay.","authors":"Umberto Carbonara,&nbsp;Daniele Amparore,&nbsp;Leonardo D Borregales,&nbsp;Anna Caliò,&nbsp;Chiara Ciccarese,&nbsp;Pietro Diana,&nbsp;Selcuk Erdem,&nbsp;Laura Marandino,&nbsp;Michele Marchioni,&nbsp;Constantijn H J Muselaers,&nbsp;Carlotta Palumbo,&nbsp;Nicola Pavan,&nbsp;Angela Pecoraro,&nbsp;Eduard Roussel,&nbsp;Hannah Warren,&nbsp;Zhen-Jie Wu,&nbsp;Riccardo Campi,&nbsp;Riccardo Bertolo","doi":"10.1177/17562872231172834","DOIUrl":"https://doi.org/10.1177/17562872231172834","url":null,"abstract":"<p><p>Single-port (SP) robotic surgery is a novel technology and is at the beginning of its adoption curve in urology. The goal of this narrative review is to provide an overview of SP-robotic partial nephrectomy (PN) 4 years after the introduction of the da Vinci SP dedicated platform, focusing on perioperative outcomes, length of stay, and surgical technique. A nonsystematic review of the literature was conducted. The research included the most updated articles that referred to SP robotic PN. Since its commercial release in 2018, several institutions have reproduced robotic PN by using the SP platform, both <i>via</i> a transperitoneal and a retroperitoneal approach. The published SP-robotic PN series are generally based on preliminary experiences by surgeons who had previous experience with conventional multi-arms robotic platforms. The reported outcomes are encouraging. Overall, three studies reported that SP-robotic PN cases had nonsignificantly different operative time, estimated blood loss, overall complications rate, and length of stay compared to the conventional 'multi-arms' robotic PN. However, in all these series, renal masses treated by SP had overall lower complexity. Moreover, two studies underlined decreased postoperative pain as a major pro of adopting the SP system. This should reduce/avoid the need for opioids after surgery. No study compared SP-robotic <i>versus</i> multi-arms robotic PN in cost-effectiveness. Published experience with SP-robotic PN has reported the feasibility and safety of the approach. Preliminary results are encouraging and at least noninferior with respect to those from the multi-arms series. Prospective comparative studies with long-term oncologic and functional results are awaited to draw more definitive conclusions and better establish the more appropriate indications of SP robotics in the field of PN.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/f0/f7/10.1177_17562872231172834.PMC10265377.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10030402","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy. 术前正常内源性睾酮水平预测根治性前列腺切除术后老年患者前列腺癌进展。
IF 2 4区 医学 Q2 UROLOGY & NEPHROLOGY Pub Date : 2023-01-01 DOI: 10.1177/17562872231154150
Antonio Benito Porcaro, Andrea Panunzio, Alberto Bianchi, Clara Cerrato, Sebastian Gallina, Emanuele Serafin, Giovanni Mazzucato, Stefano Vidiri, Damiano D'Aietti, Rossella Orlando, Davide Brusa, Matteo Brunelli, Salvatore Siracusano, Vincenzo Pagliarulo, Maria Angela Cerruto, Alessandro Tafuri, Alessandro Antonelli

Background: The impact of senior age on prostate cancer (PCa) oncological outcomes following radical prostatectomy (RP) is controversial, and further clinical factors could help stratifying risk categories in these patients.

Objective: We tested the association between endogenous testosterone (ET) and risk of PCa progression in elderly patients treated with RP.

Design: Data from PCa patients treated with RP at a single tertiary referral center, between November 2014 and December 2019 with available follow-up, were retrospectively evaluated.

Methods: Preoperative ET (classified as normal if >350 ng/dl) was measured for each patient. Patients were divided according to a cut-off age of 70 years. Unfavorable pathology consisted of International Society of Urologic Pathology (ISUP) grade group >2, seminal vesicle, and pelvic lymph node invasion. Cox regression models tested the association between clinical/pathological tumor features and risk of PCa progression in each age subgroup.

Results: Of 651 included patients, 190 (29.2%) were elderly. Abnormal ET levels were detected in 195 (30.0%) cases. Compared with their younger counterparts, elderly patients were more likely to have pathological ISUP grade group >2 (49.0% versus 63.2%). Disease progression occurred in 108 (16.6%) cases with no statistically significant difference between age subgroups. Among the elderly, clinically progressing patients were more likely to have normal ET levels (77.4% versus 67.9%) and unfavorable tumor grades (90.3% versus 57.9%) than patients who did not progress. In multivariable Cox regression models, normal ET [hazard ratio (HR) = 3.29; 95% confidence interval (CI) = 1.27-8.55; p = 0.014] and pathological ISUP grade group >2 (HR = 5.62; 95% CI = 1.60-19.79; p = 0.007) were independent predictors of PCa progression. On clinical multivariable models, elderly patients were more likely to progress for normal ET levels (HR = 3.42; 95% CI = 1.34-8.70; p = 0.010), independently by belonging to high-risk category. Elderly patients with normal ET progressed more rapidly than those with abnormal ET.

Conclusion: In elderly patients, normal preoperative ET independently predicted PCa progression. Elderly patients with normal ET progressed more rapidly than controls, suggesting that longer exposure time to high-grade tumors could adversely impact sequential cancer mutations, where normal ET is not anymore protective on disease progression.

背景:高龄对根治性前列腺切除术(RP)后前列腺癌(PCa)肿瘤预后的影响是有争议的,进一步的临床因素可以帮助对这些患者的风险分类进行分层。目的:我们测试内源性睾酮(ET)与RP治疗的老年患者PCa进展风险之间的关系。设计:回顾性评估2014年11月至2019年12月在单一三级转诊中心接受RP治疗的PCa患者的数据,并进行随访。方法:测量术前ET (> 350ng /dl)为正常。患者以70岁为截止年龄进行分组。不良病理包括国际泌尿外科病理学会(ISUP)分级>2级、精囊、盆腔淋巴结浸润。Cox回归模型检验了每个年龄亚组中临床/病理肿瘤特征与PCa进展风险之间的关系。结果:651例患者中,老年人190例(29.2%)。195例(30.0%)检测到ET水平异常。与年轻患者相比,老年患者更容易出现病理性ISUP分级组>2(49.0%对63.2%)。108例(16.6%)患者出现疾病进展,年龄亚组间无统计学差异。在老年人中,临床进展的患者比无进展的患者更有可能有正常的ET水平(77.4%对67.9%)和不利的肿瘤分级(90.3%对57.9%)。在多变量Cox回归模型中,正常ET[风险比(HR) = 3.29;95%置信区间(CI) = 1.27-8.55;p = 0.014],病理ISUP分级组>2 (HR = 5.62;95% ci = 1.60-19.79;p = 0.007)是前列腺癌进展的独立预测因子。在临床多变量模型中,老年患者更有可能在ET水平正常的情况下进展(HR = 3.42;95% ci = 1.34-8.70;P = 0.010),独立属于高危类。结论:在老年患者中,术前ET正常独立预测前列腺癌进展。正常ET的老年患者比对照组进展更快,这表明较长的高级别肿瘤暴露时间可能对顺序癌症突变产生不利影响,此时正常ET不再对疾病进展具有保护作用。
{"title":"Normal preoperative endogenous testosterone levels predict prostate cancer progression in elderly patients after radical prostatectomy.","authors":"Antonio Benito Porcaro,&nbsp;Andrea Panunzio,&nbsp;Alberto Bianchi,&nbsp;Clara Cerrato,&nbsp;Sebastian Gallina,&nbsp;Emanuele Serafin,&nbsp;Giovanni Mazzucato,&nbsp;Stefano Vidiri,&nbsp;Damiano D'Aietti,&nbsp;Rossella Orlando,&nbsp;Davide Brusa,&nbsp;Matteo Brunelli,&nbsp;Salvatore Siracusano,&nbsp;Vincenzo Pagliarulo,&nbsp;Maria Angela Cerruto,&nbsp;Alessandro Tafuri,&nbsp;Alessandro Antonelli","doi":"10.1177/17562872231154150","DOIUrl":"https://doi.org/10.1177/17562872231154150","url":null,"abstract":"<p><strong>Background: </strong>The impact of senior age on prostate cancer (PCa) oncological outcomes following radical prostatectomy (RP) is controversial, and further clinical factors could help stratifying risk categories in these patients.</p><p><strong>Objective: </strong>We tested the association between endogenous testosterone (ET) and risk of PCa progression in elderly patients treated with RP.</p><p><strong>Design: </strong>Data from PCa patients treated with RP at a single tertiary referral center, between November 2014 and December 2019 with available follow-up, were retrospectively evaluated.</p><p><strong>Methods: </strong>Preoperative ET (classified as normal if >350 ng/dl) was measured for each patient. Patients were divided according to a cut-off age of 70 years. Unfavorable pathology consisted of International Society of Urologic Pathology (ISUP) grade group >2, seminal vesicle, and pelvic lymph node invasion. Cox regression models tested the association between clinical/pathological tumor features and risk of PCa progression in each age subgroup.</p><p><strong>Results: </strong>Of 651 included patients, 190 (29.2%) were elderly. Abnormal ET levels were detected in 195 (30.0%) cases. Compared with their younger counterparts, elderly patients were more likely to have pathological ISUP grade group >2 (49.0% <i>versus</i> 63.2%). Disease progression occurred in 108 (16.6%) cases with no statistically significant difference between age subgroups. Among the elderly, clinically progressing patients were more likely to have normal ET levels (77.4% <i>versus</i> 67.9%) and unfavorable tumor grades (90.3% <i>versus</i> 57.9%) than patients who did not progress. In multivariable Cox regression models, normal ET [hazard ratio (HR) = 3.29; 95% confidence interval (CI) = 1.27-8.55; <i>p</i> = 0.014] and pathological ISUP grade group >2 (HR = 5.62; 95% CI = 1.60-19.79; <i>p</i> = 0.007) were independent predictors of PCa progression. On clinical multivariable models, elderly patients were more likely to progress for normal ET levels (HR = 3.42; 95% CI = 1.34-8.70; <i>p</i> = 0.010), independently by belonging to high-risk category. Elderly patients with normal ET progressed more rapidly than those with abnormal ET.</p><p><strong>Conclusion: </strong>In elderly patients, normal preoperative ET independently predicted PCa progression. Elderly patients with normal ET progressed more rapidly than controls, suggesting that longer exposure time to high-grade tumors could adversely impact sequential cancer mutations, where normal ET is not anymore protective on disease progression.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/94/1f/10.1177_17562872231154150.PMC9950604.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10782868","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 1
Cytomegalovirus haemorrhagic cystitis in a pregnant patient with AIDS. 艾滋病孕妇巨细胞病毒出血性膀胱炎1例。
IF 2 4区 医学 Q1 Medicine Pub Date : 2023-01-01 DOI: 10.1177/17562872231159531
Bernard Marais, Veena John, Mariëtte Du Toit, Jeanne Mbambo, Jeff John

Cytomegalovirus (CMV), an AIDS defining disease, has a high seroprevalence in the general population, while symptomatic infections occur mostly in immunocompromised individuals. Symptomatic CMV infections commonly include pneumonia, encephalitis, retinitis and colitis, while urinary tract involvement is a rare entity. We present a rare case of massive macroscopic haematuria due to CMV haemorrhagic cystitis in a 29-year-old woman in her second trimester of pregnancy. She was treated with intravenous Ganciclovir after initial resuscitation, and her symptoms promptly resolved. Timely diagnosis and treatment of symptomatic CMV infection is necessary to prevent associated morbidity, and this is especially significant during pregnancy in order to prevent foetal transmission. Both our patient and her baby remained symptom free at the 6-month follow-up post-delivery. Clinicians should have a high index of suspicion to biopsy the bladder urothelium of at-risk patients who present with haemorrhagic cystitis and have non-specific cystoscopy findings as histopathological analysis is the mainstay of diagnosing CMV-cystitis.

巨细胞病毒(CMV)是艾滋病的一种决定性疾病,在一般人群中具有很高的血清阳性率,而症状性感染主要发生在免疫功能低下的个体中。有症状的巨细胞病毒感染通常包括肺炎、脑炎、视网膜炎和结肠炎,而尿路感染是罕见的。我们报告一例罕见的巨细胞病毒出血性膀胱炎引起的大量肉眼血尿,患者为29岁,孕中期。她在初步复苏后静脉注射更昔洛韦,症状迅速缓解。及时诊断和治疗症状性巨细胞病毒感染对于预防相关发病率是必要的,这在怀孕期间尤其重要,以防止胎儿传播。在分娩后6个月的随访中,我们的患者和她的婴儿都没有出现症状。由于组织病理学分析是诊断巨细胞病毒性膀胱炎的主要方法,临床医生应高度怀疑有出血性膀胱炎和非特异性膀胱镜检查结果的高危患者的膀胱尿路上皮活检。
{"title":"Cytomegalovirus haemorrhagic cystitis in a pregnant patient with AIDS.","authors":"Bernard Marais,&nbsp;Veena John,&nbsp;Mariëtte Du Toit,&nbsp;Jeanne Mbambo,&nbsp;Jeff John","doi":"10.1177/17562872231159531","DOIUrl":"https://doi.org/10.1177/17562872231159531","url":null,"abstract":"<p><p>Cytomegalovirus (CMV), an AIDS defining disease, has a high seroprevalence in the general population, while symptomatic infections occur mostly in immunocompromised individuals. Symptomatic CMV infections commonly include pneumonia, encephalitis, retinitis and colitis, while urinary tract involvement is a rare entity. We present a rare case of massive macroscopic haematuria due to CMV haemorrhagic cystitis in a 29-year-old woman in her second trimester of pregnancy. She was treated with intravenous Ganciclovir after initial resuscitation, and her symptoms promptly resolved. Timely diagnosis and treatment of symptomatic CMV infection is necessary to prevent associated morbidity, and this is especially significant during pregnancy in order to prevent foetal transmission. Both our patient and her baby remained symptom free at the 6-month follow-up post-delivery. Clinicians should have a high index of suspicion to biopsy the bladder urothelium of at-risk patients who present with haemorrhagic cystitis and have non-specific cystoscopy findings as histopathological analysis is the mainstay of diagnosing CMV-cystitis.</p>","PeriodicalId":23010,"journal":{"name":"Therapeutic Advances in Urology","volume":null,"pages":null},"PeriodicalIF":2.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/89/5c/10.1177_17562872231159531.PMC10034270.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9245935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Therapeutic Advances in Urology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1